Industry Source Consulting (INSO) Stock Analysis & Winston Score

Winston Score History

Industry Source Consulting, Inc. is a small healthcare company operating in the specialty and generic drug manufacturing space. It focuses on pharmaceutical consulting and related services, helping clients navigate drug development, regulatory approval, and commercialization. The company serves businesses within the pharmaceutical and biotech industries rather than selling drugs directly to patients.

The company generates revenue through consulting fees and service contracts rather than product sales. It operates primarily in the United States and, based on its market capitalization, is a very early-stage or micro-cap business. The financials tell a clear story: a deeply negative gross margin of -72% and an operating margin near -966% mean the company is spending far more than it earns, which is the central risk investors face. Until the company can scale its revenue meaningfully or restructure its cost base, it remains in a high-risk financial position with no clear path to profitability visible in current results.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

-3.0% YoY

Earnings declining

Insider Activity

100.0%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~0 months

$6,230 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Industry Source Consulting has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

-168.7%

Thin — -168.7% gross margin

Profit after running costs

Operating Margin

-655.6%

Losing money on operations — -655.6%

Return on the money invested

ROCE

-6.5%

Weak — -6.5% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

—

Data not available

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

0/1 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

-9013.1%

Burning cash (-9013.1%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial